Clinical Trial Update: Albuterol to Improve Respiratory Strength in SCI [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating albuterol for improving respiratory strength in individuals with spinal cord injury and respiratory muscle weakness was terminated, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Muscle Weakness
• Spinal Cord Injury

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Spinal Cord Injury, Respiratory Muscle Weakness | Phase 4 | Status: TERMINATED | Results posted: 2024-05-07